top of page

Select Publications

  • Inoue K, Qin Y, Xia Y, Han J, Yuan R, Sun J, Xu R, Jiang J, Greenblatt M, Zhao B. Bone marrow AdipoQ-
    lineage progenitors are a major cellular source of M-CSF that dominates bone marrow macrophage
    development, osteoclastogenesis and bone mass. eLife, 2023 Feb 13;12:e82118. doi:
    10.7554/eLife.82118 (with traditional peer review and revision).
    *Highlighted by 2022 ASBMR annual meeting
    *This work was selected for a podium presentation at 2022 ASBMR annual meeting and trainee Yongli Qin
    won ASBMR travel award

  • Xia Y, Inoue K, Du Y, Baker S, E. Reddy EP, Greenblatt M, Zhao B. TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis, Nature Communications 13, 3920 (2022). https://doi.org/10.1038/s41467-022-31475-1 *Highlighted by 2021 ASBMR annual meeting, and 2022 Hot paper by JSBMR; *Highlighted by Nature Reviews Rheumatology (2022); *ASBMR Webster Jee Award

  • Deng Z, Ng C, Inoue K, Chen Z, Xia Y, Hu X, Greenblatt M, Pernis A and Zhao B. Def6 regulates endogenous type I interferon responses in osteoblasts and suppresses osteogenesis. eLife, 2020; 9: e59659. PMID: 33373293 PMC7771961

  • Inoue K, Hu X, Zhao B. Regulatory network mediated by RBP-J/NFATc1-miR182 controls inflammatory bone resorption. FASEB J. 2020;34(2):2392-2407. doi: 10.1096/fj.201902227R.

  • Xu C, Vitone G, Inoue K, Ng C, Zhao B. Identification of a novel role for Foxo3 isoform2 in osteoclastic inhibition. Journal of Immunology, 2019 Oct 15;203(8):2141-2149. *Featured cover article in the Journal of Immunology 2019

  • Nakano S, Inoue K, Xu C, Deng Z, Syrovatkina V, Vitone G, Zhao L, Huang XY, Zhao B. G-protein Gα13 functions as a cytoskeletal and mitochondrial regulator to restrain osteoclast function. Scientific Report, 2019 Mar 12;9(1):4236.

  • Inoue K, Deng Z, Chen Y, Giannopoulou E, Xu R, Gong S, Greenblatt MB, Mangala LS, Lopez-Berestein G, Kirsch DG, Sood AK, Zhao L, Zhao B. Bone protection by inhibition of microRNA-182. Nature Communications, 2018 Oct 5;9(1):4108. 

       *Featured in Nature Communications Editors' Highlights 2018
       *Highlighted by Editorial Commentary: Fassan M, Vicentini C. Role of microRNA-182 in skeletal diseases: new                    therapeutic approaches to prevent bone loss. Non-coding RNA Investig 2019;3:9.

  • Binder N, Miller C, Yoshida M, Inoue K, Nakano S, Hu X, Ivashkiv L, Schett G, Pernis A, Goldring SR, Ross FP, Zhao B. Def6 restrains osteoclastogenesis and inflammatory bone resorption, Journal of Immunology 2017 ;198(9):3436-3447.

  • Miller C, Smith S, Elguindy M, Zhang T, Xiang J, Hu X, Ivashkiv LB, Zhao B. RBP-J-regulated miR-182 promotes TNF-a-induced osteoclastogenesis. Journal of Immunology 2016, 196(12):4977-86. *Featured in the Journal of Immunology 2016

  • Li S, Miller C, Giannopoulou E, Hu X, Ivashkiv L , Zhao B. RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis. Journal Clinical Investigation. 2014 Nov 3;124(11):5057-73.

       *Featured on the NIAMS home page as the June 2015 Spotlight on Research:
       http://www.niams.nih.gov/News_and_Events/Spotlight_on_Research/2015/ra_bone_loss.asp

  • Zhao B, Takami M, Yamada A, Wang X, Koga T, Hu X, Tamura T, Ozato K, Choi Y, Ivashkiv LB, Takayanagi H, Kamijo R. Interferon regulatory factor 8 regulates bone metabolism by suppressing osteoclastogenesis. Nature Medicine 2009; 15: 1066-1071.

       *Highlighted in the article "Bone diseases: Interferon regulatory factor-8 suppresses
        osteoclastogenesis" in Nature Reviews Rheumatology 6, 73-74 (February 2010)
      *Recommended by Faculty of 1000 Medicine on Oct 9, 2009.
      *Highlighted in the Bulletin Board of Int. J. Clin. Rheumatol. 2009, 4, 5.

For more publications, please see the PubMed listing

bottom of page